SLC22A2 and cancer: Since OCT2 has been reported to mediate the toxicity of cisplatin in cancer cells and murine hair cells (Harrach and Ciarimboli, 2015), we studied the otoprotective effects of cimetidine on wild-type and TMIE-deficient hair cells.